Skip to main content
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America logoLink to Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
. 2014 Apr 29;59(3):376–383. doi: 10.1093/cid/ciu303

Differential Impact of Respiratory Syncytial Virus and Parainfluenza Virus on the Frequency of Acute Otitis Media Is Explained by Lower Adaptive and Innate Immune Responses in Otitis-Prone Children

David Verhoeven 1, Qingfu Xu 1, Michael E Pichichero 1
PMCID: PMC4155442  PMID: 24785236

Otitis-prone children have functionally diminished adaptive immune responses to respiratory syncytial virus (RSV) but not human parainfluenza virus 3. Otitis-prone children have diminished immunologic cytokine recall responses to otopathogens. A failure to control RSV may lead to deficiencies in innate clearance of otopathogens.

Keywords: adaptive immune responses, acute otitis media, otitis-prone children, respiratory syncytial virus, parainfluenza virus

Abstract

Background. Acute otitis media (AOM) is a leading cause of bacterial pediatric infections associated with viral upper respiratory infections (URIs). We examined the differential impact of respiratory syncytial virus (RSV) and parainfluenza virus URIs on the frequency of AOM caused by Streptococcus pneumoniae (Spn) and nontypeable Haemophilus influenzae (NTHi) in stringently defined otitis-prone (sOP) and non-otitis-prone (NOP) children as a potential mechanism to explain increased susceptibility to AOM.

Methods. Peripheral blood and nasal washes were obtained from sOP and NOP children (n = 309). Colonization events and antiviral responses consisting of total specific immunoglobulin G (IgG) responses, neutralizing antibody responses, and T-cell responses were determined. Isolated neutrophils were infected with varying multiplicities of infection of both viruses, and opsonophagocytosis potential was measured.

Results. A significant increase was found in frequency of AOM events caused by Spn and NTHi, with a concurrent RSV infection in sOP children. These results correlated with diminished total RSV-specific IgG, higher viral nasal burdens, and lower IgG neutralizing capacity. The sOP children had diminished T-cell responses to RSV that correlated with lower Toll-like receptor 3/7 transcript and decreased expression of HLA-DR on antigen-presenting cells. RSV interfered with the Spn phagocytic capacity of neutrophils in a dose-dependent manner. Parainfluenza virus infections did not differentially affect AOM events in sOP and NOP children.

Conclusions. Lower innate and adaptive immune responses to RSV in sOP children may slow the kinetics of viral clearance from the nasopharynx and allow for viral interference with antibacterial immune responses, thus contributing to increased frequency of AOMs.


Acute otitis media (AOM) accounts for about 30% of visits to pediatricians and is frequently caused by Streptococcus pneumoniae (Spn) or nontypeable Haemophilus influenzae (NTHi) [13]. Most past studies have relied on a clinical otoscopic examination to classify cases of AOM, and possibly 50% were misclassified [4, 5]. During a 7-year, prospective, longitudinal study we have used tympanocentesis to confirm the diagnosis of AOM and to clearly identify 2 authentic populations of children. One group we term “stringently defined otitis prone” (sOP; based on diagnosis using tympanocentesis with diagnostic microbiology) [3]. A second group we term non–otitis prone (NOP) because they have no/infrequent AOMs [3]. In our study cohort, sOPs comprise 5%–7% of all children [3].

Differences in sOP and NOP children in innate and adaptive immunological control of bacterial and viral infections could impact whether nasopharyngeal (NP) bacterial colonization during a concurrent viral upper respiratory infection (URI) proceeds to AOM, sinusitis, or pneumonia. Prior work has shown an association of AOM with concurrent respiratory syncytial virus (RSV)–induced URI [69]. RSV is also a significant pathogen in the elderly [10, 11], likely due to immunosenescence; our study may have implications for RSV infections in the elderly.

We have previously shown that sOP children have a poor adaptive immune response to Spn and NTHi [12]. Children generate antibody responses to RSV; however, memory to RSV is generally poor [13, 14]. Lower adaptive immune responses to respiratory viral infections could impact the control of viral replication in the nasal or lung mucosa.

This is the first study to examine the contribution of immune deficits in driving higher upper respiratory bacterial infection rates during RSV infection. We included human parainfluenza virus type 3 (hPIV3) as a comparator because both viruses commonly cause respiratory viral infections, albeit during different seasons of the year [15], there is no vaccine for either, and they share many similar characteristics with respect to host response modifications by viral proteins [16, 17].

MATERIALS AND METHODS

Patients

Children were enrolled at age 6 months in a prospective study and defined as sOP or NOP as previously described [13]. NP secretions were obtained from NP washes [18]. Whenever a child experienced an AOM, blood, NP secretions, and middle ear fluid were obtained by tympanocentesis. Bacterial identification was accomplished as previously reported [3]. The Rochester General Hospital research subjects review board approved the study.

Respiratory Viral Diagnosis

Viral species were identified in NP samples obtained with floxed brushes. Viral RNA was isolated using Viral RNA extraction kits (Qiagen), amplified by real-time reverse transcription polymerase chain reaction (qRT-PCR) using RSVa, RSVb, hPIV3, influenza A, influenza B, adenovirus, enterovirus, and rhinovirus kits specific for each virus (Primer Design, UK) and concentration determined per the manufacturer's instructions.

Viral Expansions

RSVa (A2), RSVb (B WV/14617/85), and hPIV3 (C 243) were obtained from ATCC (Manassas, Virginia) and grown in Hep2 cells (RSV) or LLC-MK2 cells (hPIV3) for 7 days prior to harvest. Supernatants were clarified by centrifugation at 14 000 RPM for 15 minutes, and viral aliquots were frozen at −80°C.

Antibody Assays

RSVa/b, or hPIV3 viral particles, 1 × 106/mL in phosphate-buffered saline, were heat-inactivated (65°C for 30 minutes) and added to Immulon II enzyme-linked immunosorbent assay plates (ThermoFisher, Hampton, New Hampshire) overnight at 4°C. Plates were blocked with nonfat milk. Child and reference plasma (obtained from adults with known immunoglobulin G [IgG] concentrations) antibody levels were assessed.

Viral Neutralizations

RSVa or hPIV3 (multiplicity of infection [MOI] of 1) were incubated with serially diluted plasma (heat inactivated) for 1 hour at 37°C in Dulbecco modified Eagle's medium without fetal bovine serum (FBS). RSV neutralization was determined using an MTT (Promega, Fitchburg, Wisconsin) assay [19]. hPIV3 neutralization was determined similar to other studies [20].

Hemagglutination Inhibition Titers

Hemagglutination inhibition (HAI) titers were determined as previously described [21].

Nasal Cytokine Assays

Frozen nasal washes were thawed and total protein was calibrated to 1 mg/mL using a bicinchoninic acid assay (Pierce Scientific, Rockford, Illinois). Two-hundred-microliter aliquots were assayed for cytokines by ElisaMax (BioLegend, San Diego, California) for interferon (IFN) γ, interleukin (IL) 2, IL-6, IL-1α, and IL-1β.

T-Cell Assays

Peripheral blood mononuclear cells (PBMCs) were thawed and rested overnight at 37°C. RSVa, RSVb, or hPIV3 was added at an MOI of 0.1. After 18 hours of infection, brefeldin A (10 µg/mL) and anti-CD28 (1 µg/mL) were added and cells cultured for 6 hours prior to harvest. Additional cells were cultured in the presence of brefeldin A with or without Staphylococcal enterotoxin B (positive and negative controls, respectively). Cells were surface-stained using the LIVE/DEAD amine dye (Invitrogen, Carlsbad, California) and antibodies to CD4, CD3, and CD69 (BioLegend) followed by intracellular staining for IFN-γ, IL-2, IL-4, IL-5, IL-17a, and tumor necrosis factor α (BioLegend). Data were acquired on an LSRII (BD Biosciences) with live amine dye and doublet discrimination and analyzed with FlowJo software (TreeStar, Ashland, Oregon).

Antigen-Presenting Cell Analysis

PBMCs were thawed and rested overnight at 37°C and infected with either RSVa or hPIV3 at an MOI of 0.1. HLA expression was compared by flow cytometry prior to infection and 24 hours postinfection on dendritic cells (DCs) (CD3, CD20, CD56, CD14 negative gating with HLA-DR and CD11c positive gating) with plasmacytoid dendritic cells/myeloid dendritic cells determination by antibodies for CD123 and B cells (CD3, CD56, CD14 negative gating, IgM positive staining).

qRT-PCR for Toll-like Receptors

PBMCs were thawed and rested overnight at 37°C followed by CD3 and CD20 magnetic depletion. Cellular RNA was extracted utilizing a RNA Plus extraction kit (Qiagen, Gaithersburg, Maryland). One hundred nanograms of RNA was reverse-transcribed using Superscript III (Invitrogen). qRT-PCR was used with SYBR Green (Bio-Rad, Hercules, California) to amplify targets using G3PDH as an internal calibrator or Toll-like receptor (TLR) 2, 3, 4, 7, and 8 primers designed using PrimerBank [22] (Harvard, Cambridge, Massachusetts). Data were calculated by the ΔΔCT method and expressed as fold change between groups. Each sample was amplified twice and averaged.

Phagocytosis Assay

Neutrophils were isolated from blood of sOP or NOP children by density gradient centrifugation after Ficoll separation of PBMCs. Cells were infected with increasing doses of hPIV3 or RSVa at an MOI of 0.001, 0.01, 0.1, 1, and 10, and incubated overnight at 37°C. Cells were washed and resuspended in RPMI 10% FBS with no antibiotics. Heat-treated human plasma containing type 6A capsular antibodies and rabbit complement (Thermo Fisher) at 0.1 μg/mL were added to 0.04% vol/vol Spn serotype 6A strain BG7322 [23] grown in Todd Hewitt broth (Difco) with 1% yeast extract media to an OD600 of 0.6 and prelabeled with lipophilic PKH67 dye [24]. The bacteria, antibody, and complement mix was incubated for 20 minutes at 37°C, then added to the neutrophils at a concentration of 10 bacteria per neutrophil. After 24 hours’ incubation at 37°C, cells were washed, stained with CD15, CD1c, and CD14, and analyzed by flow cytometry with double discrimination and live amine dye. Neutrophils were identified based on CD1c, CD14 negative gating with CD15 positive gating. Bacteria were identified by fluorescence of PKH67 dye in the fluorescein isothiocyanate channel.

Statistical Analysis

Data were analyzed by 2-tailed student t tests, 2-tailed Mann–Whitney U tests (data with nonnormal distribution), or Fisher exact tests, and P < .05 was considered significant.

RESULTS

The sOP and NOP cohorts were similar with respect to sex, ethnicity, frequency of breastfeeding, daycare attendance, and exposure to smokers in the home and family history of otitis media (Table 1), although sOP children were more frequently atopic (P = .05). Infected infants in the first 6 months of life may not generate innate or adaptive responses to RSV infection similar to those >6 months old, and reinfection rates in a second RSV season are high. Those not infected in a first season of exposure are likely to be infected in a second season given the winter prevalence of RSV and lack of a licensed vaccine. In the present study, children were enrolled at 6 months of age and followed until 24 months of age. To assess the role of first season of exposure as a possible confounder, we examined baseline immune status in blood obtained at 6 months of age and found that only 1 child from each group might have been infected with RSV in a prior season. We also compared the age of children in the sOP and NOP groups and found they were well matched, with a median age of 11.9 months for both cohorts.

Table 1.

Patient Characteristics

Characteristic sOP (n = 42) NOP (n = 267) P Valuea
Sex .75
 Male 59% 61%
 Female 41% 39%
Ethnicity .22
 White 82% 64%
 African American 0% 7.1%
 Asian 5.9% 7.1%
 Hispanic/Latino 5.9% 7.1%
 Other/mixed 5.9% 14.3%
Breastfeeding 1
 >6 mo 53% 50%
 <6 mo 47% 50%
Daycare .22
 None 47% 32%
 Home or center 53% 68%
Smoker in the home .51
 Yes 12% 3.6%
 No 88% 96.4%
Familial history of OM .74
 No 52.9% 42.8%
 Yes 47.1% 57.2%
Atopy .05
 No 58.2% 75%
 Yes 41.1% 25%

Abbreviations: NOP, non–otitis prone; OM, otitis media; sOP, stringently defined otitis prone.

a Significantly different (P < .05) determined by Fisher exact tests.

Association of RSV and PIV With Bacterial NP Colonization and AOM

Increased NP colonization by bacterial otopathogens during months that have higher rates of circulating respiratory viruses could drive more AOM events irrespective of the type of infecting virus. We found that sOP were more likely than NOP children to be colonized with Spn and NTHi throughout the year rather than a particular season of the year (Table 2). We previously have observed that approximately 93% of AOMs occur in the context of a concurrent viral URI, with the highest frequency of AOM during December–May in the study population (M. E. P., personal observation). Therefore, we examined the frequency of bacterial otopathogen NP colonization between December and May (peak AOMs) and June and November (few AOMs) in sOP and NOP children to determine if NP colonization corresponded to increased rates of AOMs. We found no differences (Table 2), suggesting that another causation drives rates of AOM other than frequency of colonization.

Table 2.

Colonization Rates of Cohort Patients

No. Uncolonized (Spn or NTHi) No. Colonized P Value
All months, 2009–2011
 sOP 11 52 <.001
 NOP 205 136
No. Colonized (Winter/Spring) No. Colonized (Summer/Fall) P Value
Viral seasons, 2009-2011
 sOP 32 20 .83
 NOP 87 49

P values determined by Fisher exact test.

Abbreviations: NOP, non–otitis prone; NTHi, nontypeable Haemophilus influenzae; sOP, stringently defined otitis prone; Spn, Streptococcus pneumoniae.

We next examined whether a correlation existed between frequency of Spn or NTHi NP colonization during known peak viral infection months for RSV (December–February) and hPIV3 (March–May) and concurrent development of AOM. We found that Spn/NTHi bacterial otopathogen NP colonization during RSV season was associated more often with concurrent AOM in sOP compared with NOP children (P = .02; Figure 1A and 1B). During March–May, NOP children showed a trend for more frequent NP colonization without development of AOM compared with sOP children (P = .15; Figure 1A and 1B). We examined the frequency of RSV and hPIV3 infection in sOP and NOP children with regard to infecting bacterial otopathogen and found a significant association between AOMs caused by Spn and NTHi during RSV infections in sOP children (P < .001; Figure 1C). In contrast, NOP children developed AOM with similar frequency during RSV and hPIV3 infections (Figure 1C). These data indicate that RSV infection causes AOM more frequently in sOP than NOP children, suggesting that sOP children may not respond to RSV infection as well as NOP children do.

Figure 1.

Figure 1.

A strong association between respiratory syncytial virus (RSV) and acute otitis media (AOM) in stringently defined otitis-prone (sOP) children. Frequency of nasopharyngeal colonization or AOM by bacterial otopathogens across seasons in sOP (A) and non-otitis-prone (NOP) (B) children. *1P = .021, comparing the frequency of AOM of sOP vs NOP children for similar months (n = 42 sOP, n = 267 NOP, mean). C, Frequency of RSV or human parainfluenza virus type 3 (hPIV3) in sOP and NOP children with respect to either AOM or no AOM. P < .001 comparing frequency of AOM between RSV and hPIV3 for sOP vs NOP children (n = 17 sOP and n = 65 NOP, mean). *Fisher exact tests were used for statistical analysis. Abbreviations: AOM, acute otitis media; NOP, non–otitis prone; NTHi, nontypeable Haemophilus influenzae; PIV, parainfluenza virus; RSV, respiratory syncytial virus; sOP, stringently defined otitis prone; Spn, Streptococcus pneumoniae.

Differences in Viral Load in sOP and NOP Children

Viral burden could have a significant impact on mucosa epithelial damage and inflammation that in turn may contribute to increased otopathogen bacterial load and subsequent AOM [9, 25]. We found that RSV viral burdens were higher in nasal washes of sOP vs NOP children during an AOM (P = .04; Supplementary Figure 1A). Overall, viral burden of RSVa or RSVb was higher in sOP children than in NOP children (Supplementary Figure 1B), suggesting either differential permissiveness to infection or divergent immune responses between the populations.

Children Who Are sOP Have Lower Total Specific IgG Responses to RSV but Not hPIV3

Antibody-mediated viral neutralization is a strong correlate of viral control. We found lower plasma RSV-specific IgG concentrations in sOP than NOP children (P = .02; Figure 2A). In contrast, there was no difference in titers to hPIV3 (Figure 2A). We also compared neutralizing functionality of the plasma antibodies and found that plasma Ig from sOP children had lower RSV neutralizing titers compared with NOP children (P = .04; Figure 2B). In contrast, sOP and NOP children had comparable HAI titers to hPIV3 (Figure 2C). These data indicate that lower levels of neutralizing antibodies in sOP children to RSV may allow for higher viral replication during infection.

Figure 2.

Figure 2.

Lower respiratory syncytial virus (RSV) specific antibodies during infection are associated with lower viral control in stringently defined otitis-prone (sOP) children. A, Concentration of plasma-derived immunoglobulin G (IgG)–specific antibody to RSV and human parainfluenza virus type 3 (hPIV3) in sOP and non-otitis-prone (NOP) children during an active infection (n = 10 sOP or n = 10 NOP for each viral species, geometric mean ± SD). B, Titer of neutralizing plasma IgG for RSVa in both groups of children. Reciprocal mean ± SD log2 values shown (n = 10 sOP or n = 10 NOP, mean ± SD). C, Hemagglutination inhibition titers for hPIV3 in sOP and NOP children. Reciprocal mean ± SD log2 values shown (n = 8 sOP or n = 10 NOP for each virus, mean ± SD). Two-tailed Student t tests were used. Abbreviations: HAI, hemagglutination inhibition; hPIV3, human parainfluenza virus type 3; IgG, immunoglobulin G; NOP, non–otitis prone; RSV, respiratory syncytial virus; sOP, stringently defined otitis prone.

Divergent Levels of Proinflammatory Cytokines in Nasal Mucosa During RSV and PIV

Differences in NP inflammation in sOP and NOP children could affect the frequency of otopathogen colonization as well as the density threshold of bacteria capable of causing AOM. We found that RSV infection elicited lower levels of IL-6, IL-1β, and IL-1α compared with hPIV3-infected children for both sOP and NOP cohorts (P = .05; data not shown).

Decreased T-Cell Responses to RSV in sOP Children

Diminished adaptive control could allow for continued innate inflammatory dominance during heightened and prolonged viral infection. To explore this possibility, we studied the magnitude of cytokine responses from CD4 and CD8 T cells after recall exposure to RSV and found the responses were divergent (Supplementary Figure 2A). sOP children had lower CD4 T-cell responses with fewer singlet and polyfunctional responses to RSV compared with NOP children (Supplementary Figure 2B). All cytokines were lower in sOP children; some showed a trend, while others were significant (Supplementary Figure 2B). sOP children also had fewer polyfunctional CD8 T cells (Supplementary Figure 2C). In contrast, no significant differences were identified in hPIV3-stimulated CD4 or CD8 T cells from sOP or NOP hPIV3-infected children (data not shown). These data indicate that sOP children have lower adaptive T-cell responses to RSV compared with NOP children that could affect viral control.

Lower Expression of TLR7/8 on Antigen-Presenting Cells From sOP Children

To explore a mechanism accounting for diminished responses to RSV in sOP children, we measured RNA expression (relative) of TLRs from isolated blood major histocompatibility complex class II–positive (MHCII+) antigen-presenting cells (APCs) (B cells, pDCs, and mDCs) from sOP and NOP children with no current URI. We found that expression of TLR3 was lower from MHCII+ APCs of sOP compared with NOP children (P = .05; Supplementary Figure 3A). We also examined TLR RNA expression during RSV and hPIV3 infection, concentrating on TLR7/8 expression because of its importance during single-stranded RNA activation of APCs. We found that sOP children had lower expression of TLR7 during RSV compared with hPIV3 infections (P = .04; Supplementary Figure 3B). No difference was observed in TLR8 expression from either population during RSV or PIV infections. These data indicate that lower T-cell responses in sOP children may derive in part from lower APC activation by RSV.

To determine the level of activation of APCs in sOP and NOP children during RSV and PIV infection, we measured the change in surface expression of HLA-DR (MFI) on different APC cell types prior to and after in vitro viral infection. B cells of sOP children infected with RSVa showed a lower level of induced HLA-DR expression than NOP children (P = .05; Supplementary Figure 3C). Other APCs infected with RSVa showed a trend of lower induced HLA-DR expression among sOP children (Supplementary Figure 3C). The same pattern of expression was found for RSVb (data not shown). APCs infected with hPIV3 showed a trend of lower induced HLA-DR expression in B cells among sOP children (P = .06; Supplementary Figure 3D). Again, this indicates that sOP children have lower APC responses to RSV that in turn affect their T-cell responses.

Viral Infection Interferes With Neutrophil Function

We also sought to better understand the interface of a diminished Ig neutralizing response to virus and correlative heightened viral replication in relation to neutrophil phagocytic function during AOM. We did not concentrate here on potential differences between neutrophils derived from sOP and NOP children but rather determined the effects of viral infection directly on neutrophil phagocytic function. High viral burdens not neutralized by Ig in the NP, as exhibited by sOP children, could allow RSV to move into the middle ear and infect infiltrating neutrophils or infect them prior to reflux up the Eustachian tube to the middle ear. We found that infection with hPIV3 and RSV interfered with the phagocytic capacity of neutrophils to ingest Spn in a dose-dependent manner in both groups of children with the more significant interference caused by RSV (Figure 3A and 3B). These data suggest that a failure to neutralize RSV could disrupt the capacity of neutrophils to engulf respiratory bacteria.

Figure 3.

Figure 3.

Respiratory viral infections interfere with neutrophil phagocytic capacities. Blood-derived neutrophils isolated and infected with either respiratory syncytial virus (RSV) a or human parainfluenza virus type 3 (hPIV3) in escalating multiplicities of infection (MOIs) for 24 hours. A, Phagocytic capacities of neutrophils from children were tested with PKH67-labeled Streptococcus pneumoniae (Spn). Neutrophils were identified by CD15 gating (n = 6 each group, representative flow shown for each group with an MOI of 1 for both hPIV3 and RSVa). *P < .05 between sample and no viral controls. B, Percentages of neutrophils staining positive for Spn over the range of MOIs tested for hPIV3 and RSV. *P values are between groups. Mann–Whitney U test was used for statistical analysis. Abbreviations: hPIV3, human parainfluenza virus type 3; MOI, multiplicity of infection; RSV, respiratory syncytial virus; Spn, Streptococcus pneumoniae.

DISCUSSION

In this study, we examined the association between RSV and hPIV3 respiratory viral infections and AOM in an immunologically vulnerable population (sOP) compared with an immunologically age-appropriate population (NOP) of children. To our knowledge, this is the first study to demonstrate a mechanistic association between RSV infection and extension of a bacterial secondary infection from the NP to a local infection in the form of AOM. The findings point to diminished innate and adaptive immune responses to RSV among sOP children.

We have previously shown that sOP children have an immature immune profile resembling a prolonged neonatal-like profile in responding to NTHi and Spn antigens [12, 18, 26, 27]. Here, for the first time, we show that RSV viral burdens are higher in the nasal washes of sOP vs NOP children during an AOM, and that result correlated with diminished antibody and adaptive cellular immune responses. A failure to neutralize replicating RSV in the NP could serve as a catalyst for Eustachian tube inflammation and trapping of refluxed bacteria and virus within nasal mucus. In support of this, RSV Ig treatment leads to a significant reduction of AOMs in otitis-prone children [28]. We previously found that sOP children have lower antibody responses to Spn and NTHi antigens [12, 26, 27, 29] and in this study we add lower antibody and cellular responses to RSV, suggesting a global deficiency in the adaptive immune response in sOP children.

We found that sOP children had lower T-cell responses to RSV compared with NOP children with fewer singlet/polyfunctional responses. IL-2 and IFN-γ production are both associated with protection from RSV whereas polyfunctional cytokines are associated with better control in multiple infection models [2931]. The lower observed T-cell responses in sOP children could be due to differences in antibody enhancement of T-cell activation [33], differences in stimulatory capacity of dendritic cells [34], or relate to intrinsic defects in T cells of sOP children.

Activation of APCs as part of the innate immunity response plays a significant role in the quantity and quality of the adaptive immune response. RSV can infect APCs [3537]. We found that APCs of sOP children have lower expression of TLR7 and lower induced HLA-DR expression during RSV infections. TLR7 is directly involved with clearance of viral infections and generation of adaptive responses in humans [14]. Viral activation of APCs could be the preliminary step to achieving early phagocytosis of otopathogens in the NP and driving an earlier antibacterial effector response, thus preventing AOM.

Importantly, we showed that RSV could interfere with phagocytic capacity of neutrophils to phagocytize Spn in a dose-dependent manner. In agreement, other studies have shown that RSV can infect neutrophils in infants and undergo transcription [38]; these infections could disrupt neutrophil myeloperoxidase function [39]. Therefore, RSV infection of neutrophils may initiate or further exacerbate the diminished capacity of sOP children to control otopathogen replication, a notion that we are currently investigating.

Supplementary Data

Supplementary materials are available at Clinical Infectious Diseases online (http://cid.oxfordjournals.org). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author.

Supplementary Data

Notes

Acknowledgments. We thank Dr Robert Zagursky for editorial assistance and Sheldon Perry for technical assistance.

Financial support. This work was supported by the National Institutes of Health (R01DC008671 to M. E. P. and K22AI089975 to D. V.).

Potential conflicts of interest. All authors: No reported conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

  • 1.Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29:304–9. doi: 10.1097/INF.0b013e3181c1bc48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008–2010 in Rochester NY. Pediatr Infect Dis J. 2013;38:805–9. doi: 10.1097/INF.0b013e31828d9acc. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pichichero ME, Casey JR, Almudevar A. Reducing the frequency of acute otitis media by individualized care. Pediatr Infect Dis J. 2013;32:473–8. doi: 10.1097/INF.0b013e3182862b57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media. Arch Pediatr Adolesc Med. 2001;155:1137–42. doi: 10.1001/archpedi.155.10.1137. [DOI] [PubMed] [Google Scholar]
  • 5.Pichichero M. Otitis media. Pediatr Clin North Am. 2013;60:391–407. doi: 10.1016/j.pcl.2012.12.007. [DOI] [PubMed] [Google Scholar]
  • 6.Patel JA, Nguyen DT, Revai K, Chonmaitree T. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine. 2007;25:1683–9. doi: 10.1016/j.vaccine.2006.10.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Stockmann C, Ampofo K, Hersh AL, et al. Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J. 2013;32:314–9. doi: 10.1097/INF.0b013e31827d104e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ruohola A, Pettigrew MM, Lindholm L, et al. Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect. 2013;66:247–54. doi: 10.1016/j.jinf.2012.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pettigrew MM, Gent JF, Pyles RB, Miller AL, Nokso-Koivisto J, Chonmaitree T. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol. 2011;49:3750–5. doi: 10.1128/JCM.01186-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Walsh EE, Peterson DR, Kalkanoglu AE, Lee FE, Falsey AR. Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis. 2013;207:1424–32. doi: 10.1093/infdis/jit038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets. 2012;12:98–102. doi: 10.2174/187152612800100116. [DOI] [PubMed] [Google Scholar]
  • 12.Sharma SK, Casey JR, Pichichero ME. Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation. J Infect Dis. 2012;205:1225–9. doi: 10.1093/infdis/jis179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gonzalez PA, Carreno LJ, Bueno SM, Riedel CA, Kalergis AM. Understanding respiratory syncytial virus infection to improve treatment and immunity. Curr Mol Med. 2013;13:1122–39. doi: 10.2174/1566524011313070007. [DOI] [PubMed] [Google Scholar]
  • 14.Bendelja K, Vojvoda V, Aberle N, et al. Decreased Toll-like receptor 8 expression and lower TNF-alpha synthesis in infants with acute RSV infection. Respir Res. 2010;11:143. doi: 10.1186/1465-9921-11-143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Woods CR, Bryant KA. Viral infections in children with community-acquired pneumonia. Curr Infect Dis Rep. 2013;15:177–83. doi: 10.1007/s11908-013-0324-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Henderson FW. Pulmonary infections with respiratory syncytial virus and the parainfluenza viruses. Semin Respir Infect. 1987;2:112–21. [PubMed] [Google Scholar]
  • 17.Wendt CH, Hertz MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect. 1995;10:224–31. [PubMed] [Google Scholar]
  • 18.Kaur R, Kim T, Casey JR, Pichichero ME. Antibody in middle ear fluid of children originates predominantly from sera and nasopharyngeal secretions. Clin Vaccine Immunol. 2012;19:1593–6. doi: 10.1128/CVI.05443-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rubino KL, Nicholas JA. A novel, spectrophotometric microneutralization assay for respiratory syncytial virus. J Virol Methods. 1992;39:55–67. doi: 10.1016/0166-0934(92)90125-w. [DOI] [PubMed] [Google Scholar]
  • 20.Karron RA, Makhene M, Gay K, Wilson MH, Clements ML, Murphy BR. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr Infect Dis J. 1996;15:650–4. doi: 10.1097/00006454-199608000-00003. [DOI] [PubMed] [Google Scholar]
  • 21.Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med. 2010;362:2175–84. doi: 10.1056/NEJMoa0911530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38(database issue):D792–9. doi: 10.1093/nar/gkp1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Li J, Wang JP, Ghiran I, Cerny A, et al. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune receptors. Infect Immun. 2010;78:3129–35. doi: 10.1128/IAI.01263-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Esmann L, Idel C, Sarkar A, et al. Phagocytosis of apoptotic cells by neutrophil granulocytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cells. J Immunol. 2010;184:391–400. doi: 10.4049/jimmunol.0900564. [DOI] [PubMed] [Google Scholar]
  • 25.Prince GA. An update on respiratory syncytial virus antiviral agents. Expert Opin Investig Drugs. 2001;10:297–308. doi: 10.1517/13543784.10.2.297. [DOI] [PubMed] [Google Scholar]
  • 26.Kaur R, Casey JR, Pichichero ME. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J. 2011;30:645–50. doi: 10.1097/INF.0b013e31821c2d8b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kaur R, Casey JR, Pichichero ME. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine. 2011;29:1023–8. doi: 10.1016/j.vaccine.2010.11.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Simoes EA, Groothuis JR, Tristram DA, et al. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr. 1996;129:214–9. doi: 10.1016/s0022-3476(96)70245-7. [DOI] [PubMed] [Google Scholar]
  • 29.Sharma SK, Casey JR, Pichichero ME. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis. 2011;204:645–53. doi: 10.1093/infdis/jir340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Han Q, Bagheri N, Bradshaw EM, Hafler DA, Lauffenburger DA, Love JC. Polyfunctional responses by human T cells result from sequential release of cytokines. Proc Natl Acad Sci U S A. 2012;109:1607–12. doi: 10.1073/pnas.1117194109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bueno SM, Gonzalez PA, Cautivo KM, et al. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A. 2008;105:20822–7. doi: 10.1073/pnas.0806244105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sharma SK, Pichichero ME. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012;169:281–91. doi: 10.1111/j.1365-2249.2012.04613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kruijsen D, Bakkers MJ, van Uden NO, et al. Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections. J Immunol. 2010;185:6489–98. doi: 10.4049/jimmunol.1002645. [DOI] [PubMed] [Google Scholar]
  • 34.Munir S, Hillyer P, Le Nouen C, et al. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog. 2011;7:e1001336. doi: 10.1371/journal.ppat.1001336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.McDermott DS, Weiss KA, Knudson CJ, Varga SM. Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection. Future Virol. 2011;6:963–73. doi: 10.2217/fvl.11.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jang S, Smit J, Kallal LE, Lukacs NW. Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration. J Leukoc Biol. 2013;94:5–15. doi: 10.1189/jlb.0412195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rivera-Toledo E, Gomez B. Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression. Viruses. 2012;4:3270–80. doi: 10.3390/v4123270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Halfhide CP, Flanagan BF, Brearey SP, et al. Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis. 2011;204:451–8. doi: 10.1093/infdis/jir280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Stark JM, Stark MA, Colasurdo GN, LeVine AM. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection. J Med Virol. 2006;78:829–38. doi: 10.1002/jmv.20631. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES